Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Nexgel (NXGL) Shares Issued (2019 - 2025)

Nexgel posted quarterly Shares Issued of -$92000.0 for Q4 2025, down 105.62% year-on-year from $1.6 million in Q4 2024, and down 105.62% on a QoQ basis from $1.6 million in Q4 2024.

Nexgel (NXGL) has 5 years of Shares Issued data on file, last reported at -$92000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued fell 105.62% year-over-year to -$92000.0; the trailing twelve-month figure through Dec 2025 stood at $2.7 million (down 27.52% YoY), and the FY2025 full-year result was $963000.0, down 74.47% from the prior year.
  • Shares Issued for Q4 2025 stood at -$92000.0, down from $1.6 million in the prior quarter.
  • Across five years, Shares Issued topped out at $13.2 million in Q4 2021 and bottomed at -$92000.0 in Q4 2025.
  • The 3-year median for Shares Issued is $1.1 million (2024), against an average of $2.9 million.
  • The widest annual swing landed in 2021, when Shares Issued soared 3614.37%; it then plunged 105.62% in 2025.
  • A 3-year view of Shares Issued shows it stood at $13.2 million in 2021, then plunged by 87.59% to $1.6 million in 2024, then tumbled by 105.62% to -$92000.0 in 2025.
  • The last three Shares Issued figures came in at -$92000.0 (Q4 2025), $1.6 million (Q4 2024), and $1.2 million (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 121.80 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 7.43 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 5.50 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 3.90 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 11.72 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 8.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 18.52 Mn
10 Nexgel 31,199.58 -1.34 Mn 819,000.00 -92,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -92,000.00
Dec 31, 2025 -92,000.00
Dec 31, 2024 1.64 Mn
Dec 31, 2024 1.64 Mn
Sep 30, 2024 1.19 Mn
Sep 30, 2024 1.19 Mn
Mar 31, 2024 946,000.00
Mar 31, 2024 946,000.00
Dec 31, 2021 13.19 Mn
Dec 31, 2021 13.19 Mn
Mar 31, 2021 285,000.00
Mar 31, 2021 285,000.00
Dec 31, 2020 355,000.00
Dec 31, 2020 355,000.00
Sep 30, 2020 395,000.00
Sep 30, 2020 395,000.00
Mar 31, 2020 620,000.00
Mar 31, 2020 620,000.00
Dec 31, 2019 560,000.00
Dec 31, 2019 560,000.00
Sep 30, 2019 170,000.00
Sep 30, 2019 170,000.00